-
CarDS-Plus ECG Platform: Development and Feasibility Evaluation of a Multiplatform Artificial Intelligence Toolkit for Portable and Wearable Device Electrocardiograms
Authors:
Sumukh Vasisht Shankar,
Evangelos K Oikonomou,
Rohan Khera
Abstract:
In the rapidly evolving landscape of modern healthcare, the integration of wearable & portable technology provides a unique opportunity for personalized health monitoring in the community. Devices like the Apple Watch, FitBit, and AliveCor KardiaMobile have revolutionized the acquisition and processing of intricate health data streams. Amidst the variety of data collected by these gadgets, single-…
▽ More
In the rapidly evolving landscape of modern healthcare, the integration of wearable & portable technology provides a unique opportunity for personalized health monitoring in the community. Devices like the Apple Watch, FitBit, and AliveCor KardiaMobile have revolutionized the acquisition and processing of intricate health data streams. Amidst the variety of data collected by these gadgets, single-lead electrocardiogram (ECG) recordings have emerged as a crucial source of information for monitoring cardiovascular health. There has been significant advances in artificial intelligence capable of interpreting these 1-lead ECGs, facilitating clinical diagnosis as well as the detection of rare cardiac disorders. This design study describes the development of an innovative multiplatform system aimed at the rapid deployment of AI-based ECG solutions for clinical investigation & care delivery. The study examines design considerations, aligning them with specific applications, develops data flows to maximize efficiency for research & clinical use. This process encompasses the reception of single-lead ECGs from diverse wearable devices, channeling this data into a centralized data lake & facilitating real-time inference through AI models for ECG interpretation. An evaluation of the platform demonstrates a mean duration from acquisition to reporting of results of 33.0 to 35.7 seconds, after a standard 30 second acquisition. There were no substantial differences in acquisition to reporting across two commercially available devices (Apple Watch and KardiaMobile). These results demonstrate the succcessful translation of design principles into a fully integrated & efficient strategy for leveraging 1-lead ECGs across platforms & interpretation by AI-ECG algorithms. Such a platform is critical to translating AI discoveries for wearable and portable ECG devices to clinical impact through rapid deployment.
△ Less
Submitted 10 October, 2023;
originally announced October 2023.
-
Self-supervised contrastive learning of echocardiogram videos enables label-efficient cardiac disease diagnosis
Authors:
Gregory Holste,
Evangelos K. Oikonomou,
Bobak J. Mortazavi,
Zhangyang Wang,
Rohan Khera
Abstract:
Advances in self-supervised learning (SSL) have shown that self-supervised pretraining on medical imaging data can provide a strong initialization for downstream supervised classification and segmentation. Given the difficulty of obtaining expert labels for medical image recognition tasks, such an "in-domain" SSL initialization is often desirable due to its improved label efficiency over standard…
▽ More
Advances in self-supervised learning (SSL) have shown that self-supervised pretraining on medical imaging data can provide a strong initialization for downstream supervised classification and segmentation. Given the difficulty of obtaining expert labels for medical image recognition tasks, such an "in-domain" SSL initialization is often desirable due to its improved label efficiency over standard transfer learning. However, most efforts toward SSL of medical imaging data are not adapted to video-based medical imaging modalities. With this progress in mind, we developed a self-supervised contrastive learning approach, EchoCLR, catered to echocardiogram videos with the goal of learning strong representations for efficient fine-tuning on downstream cardiac disease diagnosis. EchoCLR leverages (i) distinct videos of the same patient as positive pairs for contrastive learning and (ii) a frame re-ordering pretext task to enforce temporal coherence. When fine-tuned on small portions of labeled data (as few as 51 exams), EchoCLR pretraining significantly improved classification performance for left ventricular hypertrophy (LVH) and aortic stenosis (AS) over other transfer learning and SSL approaches across internal and external test sets. For example, when fine-tuning on 10% of available training data (519 studies), an EchoCLR-pretrained model achieved 0.72 AUROC (95% CI: [0.69, 0.75]) on LVH classification, compared to 0.61 AUROC (95% CI: [0.57, 0.64]) with a standard transfer learning approach. Similarly, using 1% of available training data (53 studies), EchoCLR pretraining achieved 0.82 AUROC (95% CI: [0.79, 0.84]) on severe AS classification, compared to 0.61 AUROC (95% CI: [0.58, 0.65]) with transfer learning. EchoCLR is unique in its ability to learn representations of medical videos and demonstrates that SSL can enable label-efficient disease classification from small, labeled datasets.
△ Less
Submitted 10 September, 2023; v1 submitted 23 July, 2022;
originally announced July 2022.
-
Deep Learning Predicts Cardiovascular Disease Risks from Lung Cancer Screening Low Dose Computed Tomography
Authors:
Hanqing Chao,
Hongming Shan,
Fatemeh Homayounieh,
Ramandeep Singh,
Ruhani Doda Khera,
Hengtao Guo,
Timothy Su,
Ge Wang,
Mannudeep K. Kalra,
Pingkun Yan
Abstract:
Cancer patients have a higher risk of cardiovascular disease (CVD) mortality than the general population. Low dose computed tomography (LDCT) for lung cancer screening offers an opportunity for simultaneous CVD risk estimation in at-risk patients. Our deep learning CVD risk prediction model, trained with 30,286 LDCTs from the National Lung Cancer Screening Trial, achieved an area under the curve (…
▽ More
Cancer patients have a higher risk of cardiovascular disease (CVD) mortality than the general population. Low dose computed tomography (LDCT) for lung cancer screening offers an opportunity for simultaneous CVD risk estimation in at-risk patients. Our deep learning CVD risk prediction model, trained with 30,286 LDCTs from the National Lung Cancer Screening Trial, achieved an area under the curve (AUC) of 0.871 on a separate test set of 2,085 subjects and identified patients with high CVD mortality risks (AUC of 0.768). We validated our model against ECG-gated cardiac CT based markers, including coronary artery calcification (CAC) score, CAD-RADS score, and MESA 10-year risk score from an independent dataset of 335 subjects. Our work shows that, in high-risk patients, deep learning can convert LDCT for lung cancer screening into a dual-screening quantitative tool for CVD risk estimation.
△ Less
Submitted 29 March, 2021; v1 submitted 16 August, 2020;
originally announced August 2020.
-
Can Deep Learning Outperform Modern Commercial CT Image Reconstruction Methods?
Authors:
Hongming Shan,
Atul Padole,
Fatemeh Homayounieh,
Uwe Kruger,
Ruhani Doda Khera,
Chayanin Nitiwarangkul,
Mannudeep K. Kalra,
Ge Wang
Abstract:
Commercial iterative reconstruction techniques on modern CT scanners target radiation dose reduction but there are lingering concerns over their impact on image appearance and low contrast detectability. Recently, machine learning, especially deep learning, has been actively investigated for CT. Here we design a novel neural network architecture for low-dose CT (LDCT) and compare it with commercia…
▽ More
Commercial iterative reconstruction techniques on modern CT scanners target radiation dose reduction but there are lingering concerns over their impact on image appearance and low contrast detectability. Recently, machine learning, especially deep learning, has been actively investigated for CT. Here we design a novel neural network architecture for low-dose CT (LDCT) and compare it with commercial iterative reconstruction methods used for standard of care CT. While popular neural networks are trained for end-to-end mapping, driven by big data, our novel neural network is intended for end-to-process mapping so that intermediate image targets are obtained with the associated search gradients along which the final image targets are gradually reached. This learned dynamic process allows to include radiologists in the training loop to optimize the LDCT denoising workflow in a task-specific fashion with the denoising depth as a key parameter. Our progressive denoising network was trained with the Mayo LDCT Challenge Dataset, and tested on images of the chest and abdominal regions scanned on the CT scanners made by three leading CT vendors. The best deep learning based reconstructions are systematically compared to the best iterative reconstructions in a double-blinded reader study. It is found that our deep learning approach performs either comparably or favorably in terms of noise suppression and structural fidelity, and runs orders of magnitude faster than the commercial iterative CT reconstruction algorithms.
△ Less
Submitted 8 November, 2018;
originally announced November 2018.
